Mirae Asset Global ETFs Holdings
LUCD icon

Mirae Asset Global ETFs Holdings’s Lucid Diagnostics LUCD Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.3K Buy
42,880
+1,020
+2% +$1.3K ﹤0.01% 2906
2025
Q4 		$45.6K Buy
41,860
+9,997
+31% +$11.2K ﹤0.01% 2954
2025
Q3 		$32.2K Sell
31,863
-5,905
-16% -$6.45K ﹤0.01% 3010
2025
Q2 		$43.4K Buy
+37,768
New +$48.8K ﹤0.01% 2909

Other funds holding LUCD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's LUCD Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Lucid Diagnostics (LUCD) stake by 2.4% in Q1 2026, buying an estimated $1.3K and bringing the position to 42,880 shares worth $49.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2906.

Mirae Asset Global ETFs Holdings first reported a position in LUCD in Q2 2025 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 42,880 shares of Lucid Diagnostics worth $49.3K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 1,020 Lucid Diagnostics shares in Q1 2026, an estimated $1.3K.
  • Lucid Diagnostics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2906 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Lucid Diagnostics in Q2 2025 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.